United Therapeutics (UTHR) Change in Account Payables (2009 - 2013)

United Therapeutics (UTHR) has 5 years of Change in Account Payables data on file, last reported at -$899000.0 in Q2 2013.

• For the quarter ending Q2 2013, Change in Account Payables fell 313.03% year-over-year to -$899000.0; the trailing twelve-month figure through Jun 2013 stood at $562000.0 (up 102.47% YoY), and the FY2012 full-year result was -$37.2 million, down 323.38% from the prior year.
• Change in Account Payables fell to -$899000.0 in Q2 2013, from $119000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $15.6 million in Q4 2011 to a low of -$39.0 million in Q1 2012.
• A 5-year average of -$1.1 million and a median of $285500.0 in 2011 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 788.59% in 2012, while the deepest fall reached 533.67% in 2012.
• Tracing UTHR's Change in Account Payables over 5 years: stood at -$922000.0 in 2009, then soared by 611.61% to $4.7 million in 2010, then jumped by 231.06% to $15.6 million in 2011, then plunged by 99.88% to $18000.0 in 2012, then slumped by 5094.44% to -$899000.0 in 2013.
• Business Quant data shows UTHR's Change in Account Payables at -$899000.0 in Q2 2013, $119000.0 in Q1 2013, and $18000.0 in Q4 2012.